These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36441800)

  • 1. Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment.
    Hallett RM; Bonfill-Teixidor E; Iurlaro R; Arias A; Raman S; Bayliss P; Egorova O; Neva-Alejo A; McGray AR; Lau E; Bosch A; Beilschmidt M; Maetzel D; Fransson J; Huber-Ruano I; Anido J; Julien JP; Giblin P; Seoane J
    Clin Cancer Res; 2023 Feb; 29(4):791-804. PubMed ID: 36441800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors.
    Borazanci E; Schram AM; Garralda E; Brana I; Vieito Villar M; Spreafico A; Oliva M; Lakhani NJ; Hoffman K; Hallett RM; Maetzel D; Hua F; Hilbert J; Giblin P; Anido J; Kelly A; Vickers PJ; Wasserman R; Seoane J; Siu LL; Hyman DM; Hoff DV; Tabernero J
    ESMO Open; 2022 Aug; 7(4):100530. PubMed ID: 35921760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth.
    McLean K; Tan L; Bolland DE; Coffman LG; Peterson LF; Talpaz M; Neamati N; Buckanovich RJ
    Oncogene; 2019 Feb; 38(9):1576-1584. PubMed ID: 30305729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel inhibitors for murine and human leukemia inhibitory factor based on fused soluble receptors.
    Metz S; Naeth G; Heinrich PC; Müller-Newen G
    J Biol Chem; 2008 Mar; 283(10):5985-95. PubMed ID: 18174171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs.
    Won H; Moreira D; Gao C; Duttagupta P; Zhao X; Manuel E; Diamond D; Yuan YC; Liu Z; Jones J; D'Apuzzo M; Pal S; Kortylewski M
    J Leukoc Biol; 2017 Aug; 102(2):423-436. PubMed ID: 28533357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8
    Pascual-García M; Bonfill-Teixidor E; Planas-Rigol E; Rubio-Perez C; Iurlaro R; Arias A; Cuartas I; Sala-Hojman A; Escudero L; Martínez-Ricarte F; Huber-Ruano I; Nuciforo P; Pedrosa L; Marques C; Braña I; Garralda E; Vieito M; Squatrito M; Pineda E; Graus F; Espejo C; Sahuquillo J; Tabernero J; Seoane J
    Nat Commun; 2019 Jun; 10(1):2416. PubMed ID: 31186412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells.
    Duluc D; Delneste Y; Tan F; Moles MP; Grimaud L; Lenoir J; Preisser L; Anegon I; Catala L; Ifrah N; Descamps P; Gamelin E; Gascan H; Hebbar M; Jeannin P
    Blood; 2007 Dec; 110(13):4319-30. PubMed ID: 17848619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
    Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.
    Seto DN; Kandarian SC; Jackman RW
    J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia inhibitory factor inhibits the proliferation of gastric cancer by inducing G1-phase arrest.
    Xu G; Wang H; Li W; Xue Z; Luo Q
    J Cell Physiol; 2019 Apr; 234(4):3613-3620. PubMed ID: 30565675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer.
    Wang MT; Fer N; Galeas J; Collisson EA; Kim SE; Sharib J; McCormick F
    Nat Commun; 2019 Jul; 10(1):3055. PubMed ID: 31296870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6 and leukemia-inhibitory factor are involved in the generation of tumor-associated macrophage: regulation by IFN-γ.
    Jeannin P; Duluc D; Delneste Y
    Immunotherapy; 2011 Apr; 3(4 Suppl):23-6. PubMed ID: 21524164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoluciferase as a novel quantitative protein fusion tag: Application for overexpression and bioluminescent receptor-binding assays of human leukemia inhibitory factor.
    He SX; Song G; Shi JP; Guo YQ; Guo ZY
    Biochimie; 2014 Nov; 106():140-8. PubMed ID: 25179300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual cytokine:Ig-domain interaction revealed in the crystal structure of leukemia inhibitory factor (LIF) in complex with the LIF receptor.
    Huyton T; Zhang JG; Luo CS; Lou MZ; Hilton DJ; Nicola NA; Garrett TP
    Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12737-42. PubMed ID: 17652170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An anti-inflammatory role for leukemia inhibitory factor receptor signaling in regenerating skeletal muscle.
    Hunt LC; Upadhyay A; Jazayeri JA; Tudor EM; White JD
    Histochem Cell Biol; 2013 Jan; 139(1):13-34. PubMed ID: 22926285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine Leukemia Inhibitory Factor Promotes Esophageal Squamous Cell Carcinoma Progression via Src Family Kinase-Dependent Yes-Associated Protein Activation.
    Kawazoe T; Saeki H; Oki E; Oda Y; Maehara Y; Mori M; Taniguchi K
    Mol Cancer Res; 2020 Dec; 18(12):1876-1888. PubMed ID: 33004621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling.
    Quaglino A; Schere-Levy C; Romorini L; Meiss RP; Kordon EC
    Breast Cancer Res; 2007; 9(5):R69. PubMed ID: 17925034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation.
    Morton SD; Cadamuro M; Brivio S; Vismara M; Stecca T; Massani M; Bassi N; Furlanetto A; Joplin RE; Floreani A; Fabris L; Strazzabosco M
    Oncotarget; 2015 Sep; 6(28):26052-64. PubMed ID: 26296968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models.
    Peng X; Hou P; Chen Y; Dai Y; Ji Y; Shen Y; Su Y; Liu B; Wang Y; Sun D; Jiang Y; Zha C; Xie Z; Ding J; Geng M; Ai J
    J Exp Clin Cancer Res; 2019 Aug; 38(1):372. PubMed ID: 31438996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.